Last reviewed · How we verify

NCT06630403

Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis

Completed Last updated 8 October 2024
What this trial tests

trial testing Demographic Data in Bronchiectasis in 40 participants. Completed in 1 January 2024.

Timeline
5 September 2023
Primary endpoint
1 January 2024
1 January 2024

Quick facts

Lead sponsorAtlas University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date5 September 2023
Primary completion1 January 2024
Estimated completion1 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Atlas University

Who can join

Adults 7 to 18, any sex, with Bronchiectasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate motor imagery ability, reaction time and cognitive function parameters in children with CF and non-CF bronchiectasis compared to healthy peers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Beyond the Pulmonary Functions: Altered Cognitive-Motor Performance and Motor Imagery in Children With Bronchiectasis.
    Temizel Tombul A, Denizoglu Kulli H, Ucgun H, Kaya M, et al · · 2026 · PMID 41865298 · DOI 10.1002/ppul.71578

Verify or expand the search:

Other recruiting trials for Bronchiectasis

Currently open trials in the same condition.

Other Atlas University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06630403.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing